Sixteen growing Alpine wethers of MIM and 2,3-DHP were found in plasma, kidney, (average BW 35 2 2 kg) were assigned to one of four and liver samples. Kidney MIM content was greater treatments to evaluate tissue retention of the leucaena ( P < .01) than that of liver, although liver tended to toxins mimosine (MIM) and 2,3-dihydroxypyridine retain slightly more 2,3-DHP ( P > .05). Infusion of (2,3-DHP). Treatments were infused i. No consuming large amounts of the leguminous forage detectable levels of either toxin were found in spleen, leucaena may be exposed to appreciable quantities of heart, lung, or muscle; however, appreciable amounts MIM and 2,3-DHP.
Introduction
There is considerable interest in the use of Leucaena Eeucocephala (leucaena) as a source of highquality forage in many parts of the world. In the rumen, mimosine is converted to 3-hydroxy-4(1H)-pyridone (3,4-DHP), some of which may be further converted to 2-hydroxy-3(1H)-pyridone ( 2,3-DHP) (Jones, 1985; Jones et al., 1985; Allison et al., 1990) . Mimosine causes alopecia and other toxic signs in various species of animals (Owen, 1958; Gupta and Akbar, 1993; Al-Dehneh et al., 1994) . The major product of ruminal mimosine metabolism is 3,4-DHP, which has been shown to be goitrogenic in various species (Hegarty et al., 1976; Christie et al., 1979; Hegarty et al., 1979) ; however, 2,3-DHP is also goitrogenic (Lee et al., 1980) . Leucaena seeds and leaves are consumed by humans in Indonesia and consumption may be high in some areas when food crop production is low, resulting in occasional cases of mimosine toxicity (Tangendjaja and Lowry, 1985) . A further potential source of ingested mimosine and the dihydroxypyridine compounds by humans is from the consumption of tissues of ruminant animals that have been consuming leucaena. Mimosine is cleared very rapidly from the body via the urine (Hegarty et al., 1964; Reis et al., 1975a,b) . However, in some countries, a variety of visceral organs, which constitute a significant part of the diet, are eaten soon after the animals are killed (Devendra and Burns, 1983; Mohd, 1989) . Data are lacking regarding potential human exposure to mimosine and both 3,4-DHP and 2,3-DHP in these circumstances. The objective of the present study was t o determine whether appreciable residues of mimosine and 2,3-DHP are found in tissues of goats following the intravenous infusion of these compounds for 48 h. Because of its commercial availability, 2,3-DHP was used as a model for both forms of DHP. In addition, because studies in the past (Crounse et al., 1962; Reis, 1975) have suggested that mimosine may interfere with other amino acids, the influence of the infusates on the concentration of amino acids in blood plasma was examined.
Materials and Methods
Sixteen Alpine wethers (8 mo of age, average BW 35 2 2 kg) were blocked by weight and randomly assigned to one of four treatment groups that received intravenous infusions for 2 d of 1) physiological saline as previously reported (Al-Dehneh et al., 1994) . The wethers were placed in individual metabolism cages and given ad libitum access to a mixed diet (Table 1) and to fresh water. Feed was offered daily at 0830, although feed was withheld during the infusion period. The goats were fitted with indwelling catheters in the right (for infusion) and left (for withdrawal of blood) jugular veins, 1 d before the start of infusion. Mimosine extracted from leucaena seed was 99% pure (Sigma Chemical, St Louis, MO) and 2,3-DHP was 98% pure (Aldrich Chemical, Milwaukee, WI). The respective treatment compounds were dissolved in physiological saline and the pH was adjusted to 7.4; the solutions were infused continuously at a rate of 10 mL/h using portable peristaltic infusion pumps (Siropump, Everest Electronics, Seaford, Australia).
Blood samples were collected from the jugular vein of each goat into two 7-mL vacuum tubes containing sodium heparin (Becton Dickinson Vacutainer System, Rutherford, N J ) at the end of the 2-d infusion.
Immediately after collection, the blood was chilled in an ice bath and centrifuged at 1,500 x g at 4" for 20 min. Plasma samples were stored at -20°C pending analysis. Within 30 min of the completion of the infusion the goats were killed with pentobarbital and exsanguinated. The viscera were removed and the liver, kidneys, heart, spleen, lung, and samples of longissimus muscle were weighed and ground using a mincer homogenizer. Samples were frozen and then freeze-dried (Consol 24; The VirTis Co., Gardiner, NY). Plasma amino acid analyses were performed by reverse-phase HPLC with an AminoQuant apparatus (Hewlett Packard, San Fernando, CA) using precolumn derivatizatiqn with o-phthalaldehyde and 9-fluorenylmethyl-chloroformate and W detection.
Plasma ( 1 mL) with added internal standard (norvaline and sarcosine, . l mL) was deproteinized with .9 mL of seraprep (Pickering, Mountain View, CA). Mimosine and 2,3-DHP were extracted from other tissues using .2 M citric acid. Approximately .5 g of freeze-dried sample was mixed with 30 mL of citric acid, homogenized, and allowed to stand for 30 min. After filtration samples were dispensed into autosampler vials. Plasma and tissue MIM and 2,3-DHP were measured using the method of Tangendjaja and Wills (1980) . Data were analyzed as a completely randomized design using the GLM procedures of SAS (1989). When treatment was significant ( P .05), means were tested using Duncan's Multiple Range Test. Differences between kidney and liver concentrations of mimosine and its metabolites were tested by a Student t-test (Steel and Torrie, 1980 ).
Results and Discussion
There were no significant differences between groups in carcass weight (mean 25 kg) and the weights of liver (720 to 820 g), spleen (60 to 80 g), kidney (200 to 250 g), heart (240 to 260 g), lungs (520 to 650 g> and blood (2400 to 2600 g). The concentrations of MIM and 2,3-DHP in liver, kidney, and plasma are shown in Table 2 . The rate of infusion of mimosine (200 mgkg BW-.75.d-1) approximates a dose of 80 m g k g l & l , which consistently allowed defleecing of sheep (Reis, 1978) . However, this dose rate in sheep was associated with a concentration of MIM in plasma of about 100 pmollL, in contrast to a mean value of 54 pmol/L observed for goats in this experiment. The concentration of MIM was 2.2-fold greater ( P < .01) in kidney than in liver, whereas the concentration of 2,3-DHP tended to be greater ( P < . l o ) in liver than in kidney. Mimoaine and 2,3-DHP in the other tissues, and all control samples, were below detectable limits (< 1 pmol/g of DM). No 2,3-DHP was detected in tissues when MIM was infused, nor was there any MIM detected in tissues when 2,3-DHP was infused. CLiver vs kidney ( P < .01).
dLiver vs kidney ( P > .lo).
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It is not surprising to find appreciable amounts of MIM and 2,3-DHP in liver and kidney samples, because large quantities of blood flow through them (Lindsay, 1993) . Moreover, it would be expected that xenobiotes such as MIM and 2,3-DHP would be detoxified in the liver and excreted into the bile (Gupta and Akbar, 1993) or excreted by the kidneys into the urine (Reis et al., 1975a,b) . If the concentration of MIM in liver and kidney is assumed to be 30 and 60 pmolig of DM (see Table 21 , it can be calculated that an individual consuming 200 g of fresh liver or kidney would ingest approximately 300 and 600 mg, respectively, of MIM.
In ruminants (i.e., sheep) these amounts of MIM may not be enough to produce serious toxic effects; however, it is not known what effects these levels may have in humans. The toxicity of many compounds is known to vary widely among species, and at present there is not sufficient information available on the toxicity of MIM to humans. Infants and adults with inadequate nutrient intake may be especially vulnerable to leucaenarelated toxicosis (Reis and Tunks, 1978) .
The major route of absorbed MIM and dihydroxypyridine (both 2,3-and 3,4-DHP) excretion is in the urine. Mimosine is readily absorbed from the gastrointestinal tract of rats and sheep and is excreted rapidly by the kidneys into the urine (Hegarty et al., 1964; Tsai and Ling, 1974; Reis et al., 1975a,b) . Although there are no data available to indicate the amount of DHP and MIM that would need to be ingested to cause deleterious effects in humans, it would be beneficial to know the potential quantities of MIM and DHP ingested when liver and kidneys from animals fed leucaena are consumed. In some tropical countries liver and kidneys are consumed fresh without processing and are considered a delicacy. The nomadic tribes in East Africa and the highlanders of Ethiopia consume animal blood as part of their diet (personal observation) and, in these circumstances, MIM and DHP could readily be ingested by humans. The impact of these practices on infants and fetal development in humans needs further investigation because there is clear evidence that MIM acts as an antimitotic agent by inhibiting DNA replication (Ward and Harris, 1976; Mosca et al., 1992) . Studies with sheep have shown that the effectiveness of MIM as a defleecing agent was influenced by the level of nutrition (Reis and Tunks, 1978) . Thus, the provision of a high intake of energy, together with large amounts of amino acids available for absorption from the small intestines, prevented defleecing with a standard i.v. infusion of MIM. Fasting or a low dietary intake tended to enhance the concentration of MIM in sheep plasma at a given rate of intravenous infusion. If these effects are applicable to humans, mimosine may be more toxic for individuals at a low plane of nutrition than for those receiving an adequate supply of nutrients.
The concentrations of plasma amino acids following the infusion of MIM, 2,3-DHP, and MIM + 2,3-DHP are shown in Table  3 . Infusion of MIM decreased ( P < .O 1) the concentrations of the essential amino acids phenylalanine and leucine. Mimosine did not alter ( P > . l o ) plasma levels of any of the nonessential amino acids measured. When 2,3-DHP was infused alone the concentrations of arginine, phenylalanine, isoleucine, leucine, lysine, and alanine increased ( P < .05). When MIM+2,3-DHP was administered, plasma arginine, lysine, and alanine concentrations were elevated ( P < .05).
The effects of MIM on the concentration of amino acids reported here differ from those reported for serum amino acids in rats consuming MIM (El-Harith et al., 1981) ; they observed small increases in glycine, citrulline, and lysine and small decreases in tyrosine, hydroxyproline, and glutamine. This apparent discrepancy may be related to species differences in amino acid metabolism and utilization (Lobley, 1992) . The biological significance of the changes in plasma amino acids during administration of MIM and 2,3-DHP is not known. The effects of MIM could be mediated via competition with normally circulating amino acids for transport systems (Christensen, 1964) ; however, the greater effects of 2,3-DHP may be due to some other mechanism.
Effects on the b,c,dValues in rows with different superscripts differ. NS, P > .lo; 'P < .lo; *P < .05; **P < .01.
branched-chain amino acids leucine and isoleucine may be especially significant because they are known to play an important role in the regulation of protein and amino acid metabolism (Lobley, 1992) .
Implications
Humans consuming fresh tissues, such as liver, kidney, or blood, from ruminants that have consumed leucaena could ingest appreciable quantities of the toxins mimosine and dihydroxypyridine. Further research is needed to determine whether serious toxic effects in humans are likely. Both mimosine and dihydroxypyridine influence the concentration of some amino acids in blood plasma of goats, but the biological significance of these changes is not known.
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